Cargando…
Prioritization of patients for germline testing based on tumor profiling of hematopoietic malignancies
Germline predisposition to hematopoietic malignancies is more common than previously appreciated, with several clinical guidelines advocating for cancer risk testing in an expanding pool of patients. As molecular profiling of tumor cells becomes a standard practice for prognostication and defining o...
Autor principal: | Godley, Lucy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923095/ https://www.ncbi.nlm.nih.gov/pubmed/36793609 http://dx.doi.org/10.3389/fonc.2023.1084736 |
Ejemplares similares
-
Clinical Assessment and Diagnosis of Germline Predisposition to Hematopoietic Malignancies: The University of Chicago Experience
por: Desai, Ami V., et al.
Publicado: (2017) -
Germline and somatic drivers in inherited hematologic malignancies
por: Zoller, Julian, et al.
Publicado: (2023) -
Challenges associated with the identification of germline variants on myeloid malignancy genomic profiling—a Singaporean experience
por: Chin, Hui-Lin, et al.
Publicado: (2023) -
Megakaryocytes Are Regulators of the Tumor Microenvironment and Malignant Hematopoietic Progenitor Cells in Myelofibrosis
por: Varricchio, Lilian, et al.
Publicado: (2022) -
Clinical considerations at the intersection of hematopoietic cell transplantation and hereditary hematopoietic malignancy
por: O’Connor, Timothy E., et al.
Publicado: (2023)